Healthcare Market Research Reports and Trends

Healthcare supply chain management is the practice of developing efficient supply chain methods by stakeholders in the healthcare arena to achieve operational efficiency and traceability while reducing operating costs without compromising quality. The adoption of healthcare supply chain management solutions offers significant benefits to various stakeholders involved in the supply chain, such as healthcare providers, distributors, and suppliers. Globally, there is an increasing focus among stakeholders to reduce their operating costs by achieving operational efficiency. The adoption of supply chain solutions helps them achieve these objectives, and thus the demand for these solutions is increasing across the globe. The  global healthcare supply chain management market  is projected to reach USD 2.31 billion by 2022 from an estimated USD 1.55 billion in 2017, growing at a CAGR of 8.4% during the forecast period.  Increasing pressure on healthcare providers to improve operational e

The growth of this market is majorly driven by the rising geriatric population (and the subsequent increase in the prevalence of chronic diseases), shift from volume- to value-based care, and delays in drug development (and the subsequent increase in development costs). The  global real world evidence solutions market  is projected to reach USD 1,348.1 million by 2023 from USD 689.9 million in 2018, at a CAGR of 14.3% during the forecast period.   The rising focus on end-to-end RWE services and growth opportunities in emerging markets are expected to provide further growth opportunities for players operating in the real world evidence market. However, the reluctance to rely on real-world studies and the lack of universally accepted methodological standards for data collection some of the factors limiting the growth of this market during the forecast period. The real-world evidence market is broadly segmented into four major regions, namely, North America, Europe, Asia Pacific,

Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries. In addition, the emerging markets and growth in the number of hospitals and surgical centers are expected to offer further growth opportunities for players operating in the hemostats market during the forecast period. The  global hemostats market  is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%.  The hemostats market is segmented into neurological surgery, cardiovascular surgery, general surgery, orthopedic surgery, thoracic surgery, gynecological surgery, urological surgery, and reconstructive surgery. The orthopedic surgery segment is expected to account for the largest share of the hemostats market in 2018. The growing geriatric population, increasing incidence of

The biomaterials market is projected to reach USD 149.17 Billion by 2021 from USD 70.90 Billion in 2016, at a CAGR of 16.0%.  The growth of the overall market can be attributed to increased funds & grants by government bodies worldwide, the growing implantable devices market, technological advancements, rising number of hip and knee replacement procedures, and high growth in geriatric population coupled with growing incidence of cardiovascular diseases. Don’t miss out on business opportunities in biomaterials market. Speak to our analyst and gain crucial industry insights that will help your business grow. This report segments the biomaterials market based on type of material, application, and region. On the basis of type of material, the metallic biomaterials segment is expected to account for the largest share of the global market, in 2016; owing to their unique properties such as biocompatibility, strength, and resistance to breakage, which makes them suitable for usage in

Regulatory mandates in the healthcare industry to maintain compliance with Good Manufacturing Practices, increasing number of inspection checkpoints in production lines, growing number of product recalls, rising penetration of automated inspection systems in the pharmaceutical & biotechnology industries, and technological evolution in inspection systems are the major factors driving the growth of this market. The global  inspection machines market  is projected to reach USD 774 million by 2024 from USD 592 million in 2019, at a CAGR of 5.5%. Fully automated inspection machines segment to account for the largest share of the inspection machines market, by type, in 2019 The fully automated machines segment is expected dominate the inspection machines market, by type, in 2019. The large share of this segment can majorly be attributed to advantages offered by fully automated inspection machines (such as high-throughput, maximum inspection accuracy, high detection rate, and co

Portable analytical instruments are lightweight handheld instruments with simple infrastructure and deliver instant results, in any location and under any weather condition. The  portable analytical instruments market  is projected to reach USD 9.55 Billion by 2020 from USD 8.10 Billion in 2015, at a CAGR of 3.3%.  The major drivers for the market include the growing food and environmental concerns; benefits of portable analytical instruments such as low cost and easy to operate; and increasing healthcare expenditure. To speak to our analyst for a discussion on the above findings, click  Speak to Analyst In this report, the global portable analytical instruments market is segmented based on product, technology, end user, and region. By product, the market includes TOC analyzers, dissolved carbon dioxide & oxygen meters, titrators, refractometers, pH meters, spectrometers, gas analyzers, conductivity & resistivity meters, colorimeters, thermal analyzers, and others (th

Fluoroscopy is a technique that displays multiple x-rays to generate real-time still images or a video of the patient’s body. It is a commonly used medical technique that helps physicians with a wide variety of diagnostic and interventional procedures. The global  fluoroscopy equipment market  is projected to reach USD 2.79 Billion by 2022 from USD 2.12 Billion in 2016 at a CAGR of 4.8% during the forecast period. The key factors driving the growth of this market include the technological advancements in the fluoroscopic equipment, growing popularity of multipurpose imaging and minimally invasive procedures, and use of fluoroscopy in pain management. Base year considered for the report is 2016 and forecast period considered is 2017-2022. To know about the assumptions considered for the study,  download the pdf brochure The risk of radiation exposure from fluoroscopy procedures is likely to restrain market growth. Fluoroscopy procedures are time-con

Factors such as the increasing adoption of telomere performance programs for leading a healthy life; growing importance of healthy life expectancy (HALE); rising government focus towards preventive healthcare; rising geriatric population and resultant growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach; and the increasing burden of chronic diseases are expected to drive the growth of this market. On the other hand, problems associated with the transport of samples and differences in the cost of test kits offered by different companies are expected to restrain the growth of this market during the forecast period. The global  Cellular Health Screening Market  is expected to reach USD 3.42 billion by 2022 from USD 2.12 billion in 2017, at a CAGR of 10.0% during the forecast period. Major Market Developments: In 2016, Telomere Diagnostics launched TeloYears, its new telomere test. In 2015, SpectraCel

Factors contributing to the growth of this market include the benefits of cold plasma, such as its environment-friendliness; innovations in textile production; growing food safety concerns; innovations in cold plasma technology; and the increasing use of cold plasma in meat and poultry packaging decontamination. The surface treatment segment to witness the highest growth during the forecast period The surface treatment segment accounted for the largest share of the  cold plasma market  for the polymer and plastic industry. This market segment is majorly driven by the advantages of cold plasma surface treatment, such as increased durability, better hydrophobic properties, higher packing density, better film quality, enhanced coating surface smoothness, and lower cost. Global Cold plasma Market for Textile Industry By Application Finishing Dyeing/Printing Sterilization Others By Regime Atmospheric Cold Plasma Low Pressure Cold Plasma Global Cold plasma Market for

Factors such as high prevalence of hearing loss, rising geriatric population, and technological advancements in hearing aids are driving the global market. This report segments the  hearing aids market , type of hearing loss, patient type, and region. Based on the product, the market is segmented into hearing aid devices and hearing implants. The hearing aid devices segment is expected to account for the largest share of the global market in 2017. Hearing Aids Market –  Scope of the Report This report categorizes the global market into the following segments and subsegments: Hearing Aids Market, by Product Hearing Aid Devices Receiver-In-The-Ear (RITE) Hearing Aids Behind-The-Ear (BTE) Hearing Aids Canal Hearing Aids In-The-Ear (ITE) Hearing Aids Other Hearing Aid Devices Hearing Implants Cochlear Implants Bone-anchored Systems Hearing Aids Market, by Type of Hearing Loss Sensorineural Hearing Loss Conductive Hearing Loss Hearing Aids Market, by Patient Type

Rising awareness about advanced wound care is expected to hinder the growth of the medical tapes market. Advanced wound accelerates the healing process for many chronic wounds by providing and promoting a moist environment. As basic/traditional wound care products take a large amount of time to heal wounds and are less effective for certain types of wounds, advanced wound care products are being used as first-line therapy wherever infection control and healing speed are major concerns.  Considering their effectiveness, coupled with the limitations of basic/traditional wound dressings, advanced and active wound care products are seen as a prominent restraint for the market. The global medical bandages market is projected to reach USD 7.39 Billion by 2022 from 6.13 Billion in 2017, at a CAGR of 3.8%.   Some of the factors driving the growth of this market are the increasing number of surgeries and the growth in geriatric population. The  medical tapes and bandages mark